Status:
COMPLETED
The Effect of Protein Supplement on Lean Body Mass in Patients With Pneumonia
Lead Sponsor:
Nordsjaellands Hospital
Conditions:
Community-acquired Pneumonia
Eligibility:
All Genders
60+ years
Phase:
NA
Brief Summary
The purpose of this clinical trial is to reduce the patient's loss of lean body mass by protein supplementation during hospitalization and 60 days after hospital discharge. Also, the study aims to red...
Detailed Description
Infections are globally the biggest cause of mortality. In Denmark community acquired pneumonia is one of the most common causes for infections in patients. Mortality in pneumonia has been stable high...
Eligibility Criteria
Inclusion
- Hospitalized patients with community acquired pneumonia
- \>60 years
- Patients who are able to speak and understand Danish
Exclusion
- Patients with hospitalized acquired pneumonia
- Patients with septic shock
- Patients with an active cancer and in cancer treatment
- Patients in dialysis
- ICU patients
- Patients unable or unwilling to give informed consent
Key Trial Info
Start Date :
January 15 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2019
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT03774953
Start Date
January 15 2019
End Date
June 30 2019
Last Update
September 13 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Nordsjaellands hospital
Hillerød, Denmark